A detailed history of Lecap Asset Management LTD transactions in Exact Sciences Corp stock. As of the latest transaction made, Lecap Asset Management LTD holds 8,705 shares of EXAS stock, worth $525,520. This represents 0.13% of its overall portfolio holdings.

Number of Shares
8,705
Holding current value
$525,520
% of portfolio
0.13%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$42.43 - $70.83 $369,353 - $616,575
8,705 New
8,705 $593 Million
Q1 2024

Apr 25, 2024

BUY
$56.27 - $73.77 $834,484 - $1.09 Million
14,830 New
14,830 $1.02 Billion

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.7B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Lecap Asset Management LTD Portfolio

Follow Lecap Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lecap Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Lecap Asset Management LTD with notifications on news.